These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 29595761)

  • 21. Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin.
    Efeyan A; Ortega-Molina A; Velasco-Miguel S; Herranz D; Vassilev LT; Serrano M
    Cancer Res; 2007 Aug; 67(15):7350-7. PubMed ID: 17671205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer.
    Deben C; Wouters A; Op de Beeck K; van Den Bossche J; Jacobs J; Zwaenepoel K; Peeters M; Van Meerbeeck J; Lardon F; Rolfo C; Deschoolmeester V; Pauwels P
    Oncotarget; 2015 Sep; 6(26):22666-79. PubMed ID: 26125230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway.
    Zauli G; Rimondi E; Corallini F; Fadda R; Capitani S; Secchiero P
    J Bone Miner Res; 2007 Oct; 22(10):1621-30. PubMed ID: 17592964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wilms' tumor gene 1 enhances nutlin-3-induced apoptosis.
    Lee SY; Choe YJ; Park JY; Lee SS; Kim YH; Shin SJ; Chung YJ; Kim HS
    Oncol Rep; 2014 Jan; 31(1):131-6. PubMed ID: 24190574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifibrotic Effects of Sakuraso-Saponin in Primary Cultured Pterygium Fibroblasts in Comparison With Mitomycin C.
    Lee H; Jeong H; Lee CM; Shin JA; Jang SW; Lee JH; Park SY; Kim JY; Tchah H
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4784-4791. PubMed ID: 31743935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Two Techniques for the Treatment of Recurrent Pterygium: Amniotic Membrane vs Conjunctival Autograft Combined with Mitomycin C.
    Katırcıoglu YA; Altiparmak U; Engur Goktas S; Cakir B; Singar E; Ornek F
    Semin Ophthalmol; 2015; 30(5-6):321-7. PubMed ID: 24506693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nutlin-3 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulation of death receptor 5 (DR5) in human sarcoma HOS cells and human colon cancer HCT116 cells.
    Hori T; Kondo T; Kanamori M; Tabuchi Y; Ogawa R; Zhao QL; Ahmed K; Yasuda T; Seki S; Suzuki K; Kimura T
    Cancer Lett; 2010 Jan; 287(1):98-108. PubMed ID: 19577358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A.
    Müller CR; Paulsen EB; Noordhuis P; Pedeutour F; Saeter G; Myklebost O
    Int J Cancer; 2007 Jul; 121(1):199-205. PubMed ID: 17354236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutlin-3 downregulates the expression of the oncogene TCL1 in primary B chronic lymphocytic leukemic cells.
    Voltan R; di Iasio MG; Bosco R; Valeri N; Pekarski Y; Tiribelli M; Secchiero P; Zauli G
    Clin Cancer Res; 2011 Sep; 17(17):5649-55. PubMed ID: 21753157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial.
    Chen R; Huang G; Liu S; Ma W; Yin X; Zhou S
    Graefes Arch Clin Exp Ophthalmol; 2017 Feb; 255(2):375-385. PubMed ID: 27761704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
    Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
    J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted delivery of mitomycin C-loaded and LDL-conjugated mesoporous silica nanoparticles for inhibiting the proliferation of pterygium subconjunctival fibroblasts.
    Wu M; Wang S; Wang Y; Zhang F; Shao T
    Exp Eye Res; 2020 Aug; 197():108124. PubMed ID: 32598971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutlin-3 down-regulates retinoblastoma protein expression and inhibits muscle cell differentiation.
    Walsh EM; Niu M; Bergholz J; Xiao ZX
    Biochem Biophys Res Commun; 2015 May; 461(2):293-9. PubMed ID: 25871794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of treatment for pterygium by autologous conjunctival transplantation and mitomycin C.
    Xu Y; Zhou HM; Li J; Ke BL; Xu X
    Chin Med J (Engl); 2012 Oct; 125(20):3730-4. PubMed ID: 23075733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjunctival autografting combined with low-dose mitomycin C for prevention of primary pterygium recurrence.
    Frucht-Pery J; Raiskup F; Ilsar M; Landau D; Orucov F; Solomon A
    Am J Ophthalmol; 2006 Jun; 141(6):1044-1050. PubMed ID: 16546105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDM2 inhibitor Nutlin-3a suppresses proliferation and promotes apoptosis in osteosarcoma cells.
    Wang B; Fang L; Zhao H; Xiang T; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2012 Aug; 44(8):685-91. PubMed ID: 22843172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of mitomycin C on corneal endothelium in pterygium surgery.
    Bahar I; Kaiserman I; Lange AP; Slomovic A; Levinger E; Sansanayudh W; Slomovic AR
    Am J Ophthalmol; 2009 Mar; 147(3):447-452.e1. PubMed ID: 18992871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study on the safety and efficacy of combined conjunctival rotational autograft with intraoperative 0.02% mitomycin C in primary pterygium excision.
    Young AL; Tam PM; Leung GY; Cheng LL; Lam PT; Lam DS
    Cornea; 2009 Feb; 28(2):166-9. PubMed ID: 19158559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73.
    Peirce SK; Findley HW
    Int J Oncol; 2009 May; 34(5):1395-402. PubMed ID: 19360352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (R)-roscovitine (CYC202, Seliciclib) sensitizes SH-SY5Y neuroblastoma cells to nutlin-3-induced apoptosis.
    Ribas J; Boix J; Meijer L
    Exp Cell Res; 2006 Jul; 312(12):2394-400. PubMed ID: 16765943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.